You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
未名醫藥(002581.SZ):擬設立全球生物安全與創新研究院並聘請馬力擔任院長兼戰略顧問
格隆匯 12-06 19:38

格隆匯12月6日丨未名醫藥(002581.SZ)公佈,為適應公司戰略發展需要,持續提升公司核心競爭力,公司決定設立“全球生物安全與創新研究院”作為主要部門,制定、監督及落實各子公司及各流程中的生物安全制度,構建生物安全屏障,並聘任馬力擔任全球生物安全與創新研究院院長兼戰略顧問一職。

公司業務涉及毒株、疫苗、細胞等重要生物資源的全流程管理,包括收集、滅活、製備、使用、倉儲、運輸等,因此,公司設立專門的“全球生物安全與創新研究院”部門,制定完備並符合國家生物安全戰略和生物安全風險防控的制度、管理辦法及操作規程,對生物資源利用的各個環節進行有效的監督和防控。公司各子公司作為國內乃至國際生物醫藥市場的重要企業,承擔毒株接收及存儲、疫苗滅活處理、病變細胞提取及存儲擴增等重要工作,掌握國家疫情防控計劃等重要生物安全信息,公司設立獨立的“全球生物安全與創新研究院”,是公司商務、生產、質量安全性運營的必備要求,對公司的生物安全風險防控具有重大意義。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account